Professor, Internal Medicine, Mayo Medical School
Endocrinology
Dr. Ian D. Hay, MD
|
|
Give Review
works in the field of Endocrinology. He received 2 awards: "Regional Top Doctor" and "Fellow (FACE)". is a published doctor as well. He has 37 publications published. The latest was: Clinical and molecular features of Hürthle cell carcinoma of the thyroid. He accepts all Medicare patients.
Publications
- Clinical and molecular features of Hürthle cell carcinoma of the Thyroid.
- Reoperative experience with papillary Thyroid cancer.
- Pediatric endocrine surgery: a 20-year experience at the mayo clinic.
- The coming of age of ultrasound-guided percutaneous ethanol ablation of selected neck nodal metastases in well-differentiated Thyroid carcinoma.
- Invasive Fibrous Thyroiditis (Riedel Thyroiditis): The Mayo Clinic Experience, 1976-2008.
- Enhanced survival in locoregionally confined anaplastic Thyroid carcinoma: a single-institution experience using aggressive multimodal therapy.
- The prognostic value of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in patients with suspected residual or recurrent medullary Thyroid carcinoma.
- Cystic change in Thyroid carcinoma: Prevalence and estimated volume in 360 carcinomas.
- Risks and adequacy of an optimized surgical approach to the primary surgical management of papillary Thyroid carcinoma treated during 1999-2006.
- Long-term outcome in 215 children and adolescents with papillary Thyroid cancer treated during 1940 through 2008.
- Managing patients with a preoperative diagnosis of AJCC/UICC stage I (T1N0M0) papillary Thyroid carcinoma: East versus West, whose policy is best?
- Graves' disease after unilateral Riedel's Thyroiditis.
- Thyroid follicular carcinoma: sonographic features of 50 cases.
- Need for a revised staging consensus in medullary Thyroid carcinoma.
- A Proposition for the Use of Radioiodine in WDTC Management.
- Papillary Thyroid microcarcinoma: a study of 900 cases observed in a 60-year period.
- 18F-FDG PET in the management of patients with anaplastic Thyroid carcinoma.
- The value of positron emission tomography in the surgical management of recurrent papillary Thyroid carcinoma.
- Management of patients with low-risk papillary Thyroid carcinoma.
- ATA Guidelines: do patients with stage I Thyroid cancer benefit from (131)I?
- Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular Thyroid carcinoma.
- Management of Thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement.
- Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary Thyroid cancer.
- Sonography of Thyroid nodules: a "classic pattern" diagnostic approach.
- Long-term trends in Thyroid carcinoma: a population-based study in Olmsted County, Minnesota, 1935-1999.
- PPARgamma staining as a surrogate for PAX8/PPARgamma fusion oncogene expression in follicular neoplasms: clinicopathological correlation and histopathological diagnost...
- Current strategies for surgical management and adjuvant treatment of childhood papillary Thyroid carcinoma.
- Effects of reducing the upper limit of normal TSH values.
- 18F-FDG PET of patients with Hürthle cell carcinoma.
- Management of brain metastases from Thyroid carcinoma: a study of 16 pathologically confirmed cases over 25 years.
- High resolution loss of heterozygosity mapping of 17p13 in Thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, pro...
- Papillary Thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively t...
- Loss of heterozygosity studies revisited: prior quantification of the amplifiable DNA content of archival samples improves efficiency and reliability.
- Lack of impact of radioiodine therapy in tg-positive, diagnostic whole-body scan-negative patients with follicular cell-derived Thyroid cancer.
- Managing patients with papillary Thyroid carcinoma: insights gained from the Mayo Clinic's experience of treating 2,512 consecutive patients during 1940 through 2000.
- Low risk papillary Thyroid cancer.
Conditions Treated
- Diabetes Type 2
- Hyperkalemia
- Hyperlipidemia
- HypoparaThyroidism
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- Regional Top Doctor
- Fellow (FACE)
Education
-
Mayo School of Graduate Medical Education -
University of Glasgow Faculty of Medicine
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1174503098 | |
| NPPES Provider LastName | HAY | |
| NPPES Provider FirstName | IAN | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 238.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1174503098 |
| Last Name Of The Provider | HAY |
| First Name Of The Provider | IAN |
| View All |
Similar Doctors
|
|
Dr. Vitaliano Sicilia, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bart L. Clarke, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Yogish C. Kudva, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Helen Karakelides, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vahab Fatourechi, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Galina V. Smushkin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mabel M. Ryder, MD
This Doctor is OpenDoctor Recommended.
|